Dr. Bunn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1973 - 1976
University of California (San Francisco)Residency, Internal Medicine, 1971 - 1973
Weill Cornell MedicineClass of 1971
Certifications & Licensure
CO State Medical License 1984 - 2025
MD State Medical License 1973 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer Start of enrollment: 1995 Oct 10
- S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer Start of enrollment: 1999 Oct 01
- Lung Cancer Mutation Consortium Protocol Start of enrollment: 2009 Sep 16
Publications & Presentations
PubMed
- Reply to P. de Boissieu et al.David R Spigel, Afshin Dowlati, Yuanbin Chen, Alejandro Navarro, James Chih-Hsin Yang
Journal of Clinical Oncology. 2025-01-20 - The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitiz...Tejas Patil, Dexiang Gao, Alexander Watson, Mandy Sakamoto, Yunan Nie
Lung Cancer. 2025-01-01 - Calls to action on lung cancer management and research.May-Lucie Meyer, Fred R Hirsch, Paul A Bunn, Peter Ujhazy, David Fredrickson
The Oncologist. 2024-12-06
Press Mentions
Major Project to Address ‘Urgent Need’ for Improved Testing of Cancer TherapiesAugust 21st, 2024- Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company ProgressAugust 2nd, 2021
- With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma BuyoutJune 25th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
